HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

E Tech Group Secures New...

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

ROM InWest Invests €1.5 million...

April 10, 2024

The investment will allow ROM InWest to further distribute its fall detection product globally.

E Tech Group Secures New Investment from Graham Partners, Sets Stage for Continued Growth and Innovation

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

HAPPE Spine Announces Close Of $3.35 Million Round In Series A Investment

The oversubscribed funding was led by strategic investors from within the spine industry along with prominent and continuing investment by the Genesis Innovation Group's cultivate(MD) Seed II Fund.

November 8, 2021

Gyroscope Announces Sanofi Equity Investment of up to $60 Million

The investment further validates the potential of Gyroscope’s gene therapy GT005 for the treatment of Geographic Atrophy, one of the world’s leading causes of blindness, and supports its ongoing Phase II development programs.

November 8, 2021

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

November 2, 2021

LightForce Orthodontics Secures $50 Million Series C Funding

“LightForce’s innovative approach to an industry that has lacked technological disruptiveness for the past 25 years is what initially attracted us to this investment opportunity,” said Wen Hsieh, partner, Kleiner Perkins.

November 2, 2021

New View Surgical, Inc. Closes $9M Series B Financing

The round was led by members of New York Angels with Corza Medical, Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others participating in the round.

November 2, 2021

Innoventric Ltd., Wins the Prestigious Horizon Europe Grant

Amir Danino, Founder and CEO, said: In the last decade structural heart interventions have become extremely complex and risky. This is manifested, among else, by the duration of these procedures and by their sub-optimal technical success rates.

November 1, 2021

Magnus Medical Launches With Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

The Magnus System is based on the SAINT technology, which was licensed exclusively to Magnus Medical from Stanford University for commercialization.

October 29, 2021

iApotheca Healthcare Inc. Announces Closing of $470K Angel Funding Round

"Leva Capital is thrilled to announce the addition of iApotheca into our investment portfolio," said Eddie Gobran, Managing Partner. "Their strategy aligns with our vision of investing in health technology that will improve the healthcare experience for Canadians. We are confident in iApotheca's team to execute their strategy and deliver a great experience to pharmacies across Canada."

October 29, 2021

Exosystems Raises $3.9M Series A Funding

With the latest investments, Exosystems plans to expand clinical & technical capabilities to further develop the company's technology and overseas business.

October 28, 2021